Three-dimensional Kinematic Motion Analysis of Finger and Wrist During Daily Activities

October 29, 2018 updated by: University of Zurich

Three-dimensional Kinematic Motion Analysis of Finger and Wrist During Daily

Development of reliable and objective evaluation methods is required for natural upper-extremity tasks. Three-dimensional imaging measurement techniques are a powerful tool for quantitative assessment of multijoint movements.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • ZH
      • Zurich, ZH, Switzerland, 8091
        • University Hospital Zurich, Center for Reconstructive Surgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population consists of healty persons, patients with tendon pathologies, arthrosis and dupuytren disease. In the future the new findings should assist the decision of surgical procedures.

Description

Inclusion Criteria:

  • Volunteers of 20 healthy, right dominant hands
  • 10 patients with tendon pathologies
  • 10 patients with Dupuytren disease
  • 10 patients with osteoarthritis of the wrist
  • Patients older than 18 years
  • Patient willing and able to give written informed consent to participate in the study

Exclusion Criteria:

  • Inflammatory disease (e.g. rheumatoid arthritis)
  • Pregnant women
  • German language barrier to complete the questionnaires
  • Any disease process that would preclude accurate evaluation (e.g. neuromuscular, psychiatric or metabolic disorder)
  • Legal incompetence
  • Participation in any other medical device or medicinal product study within the previous months that could influence the results of the present study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
20 healthy volunteers
Dupuytren disease
10 patients dupuytren disease
Tendon pathology
10 patients with tendon pathology
wrist osteoarthritis
10 patients with wrist osteoarthritis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Joint angle of finger and wrist (Vicon)
Time Frame: 36 months
Position of the Skin markers be measured with the Vicon cameras and the Joint angles will be calculated with matlab program. Maximum range of motion will be compared between first and second measurement.
36 months
Joint angle of finger and wrist (Goniometer)
Time Frame: 36 months
Maximum range of motion will be compared between first and second measurement
36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective functional parameters: - daily activities: open a bottle, open a glass, type 3 words, write 3 words, turn a key, pick up small object, move heavy object (1/3kg), dart-throwing motion
Time Frame: 36 months
Position of the Skin markers be measured with the Vicon cameras during daily activities and the joint angles will be calculated with matlab program.
36 months
Subjective functional parameters: - Mayo Wrist Score - Krimmer Wrist Score - Short Version of the Disability of the Arm, Shoulder and Hand questionnaire (QuickDASH)
Time Frame: 36 months

Mayo Wrist Score: On a scale from 0-100 points, 91-100 points is a excellent result, 81-90 a good results, 65-80 a satisfactory result and less than 65 points a poor result Krimmer Wrist Score: On a scale from 0-100 points, more than 80 is a excellent result, 65-80 a good result, 50-65 a satisfactory result and 0-50 a poor result.

QuickDASH: At least 10 of the 11 items must be completed for a score to be calculated. The assigned values for all completed responses are simply summed and averaged, producing a score out of five. This value is then transformed to a score out of 100 by subtracting one and multiplying by 25. This transformation is done to make the score easier to compare to other measures scaled on a 0-100 scale. A higher score indicates greater disability.

36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maurizio Calcagni, PD Dr. med., Plastic surgery and Handsurgery USZ

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2016

Primary Completion (ACTUAL)

December 1, 2017

Study Completion (ACTUAL)

December 1, 2017

Study Registration Dates

First Submitted

August 18, 2016

First Submitted That Met QC Criteria

August 31, 2016

First Posted (ESTIMATE)

September 7, 2016

Study Record Updates

Last Update Posted (ACTUAL)

October 30, 2018

Last Update Submitted That Met QC Criteria

October 29, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KEK-ZH-Nr. 2015-0395

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hand Injuries

3
Subscribe